» Articles » PMID: 12586513

Galactose-PEI-DNA Complexes for Targeted Gene Delivery: Degree of Substitution Affects Complex Size and Transfection Efficiency

Overview
Specialty Pharmacology
Date 2003 Feb 15
PMID 12586513
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Complexes of galactosylated polyethylenimines (gal-PEI) with DNA have been proposed for gene delivery to hepatocytes. We synthesized gal-PEI with a broad range of degrees of substitution (DS) ranging from 3.5 to 31% of all PEI amino groups by reductive amination to determine physico-chemical and biological properties with respect to the DS. Gel retardation assay for herring testes DNA-polymer polyplexes showed that increasing DS compromised DNA complexation and especially condensation. Using photon correlation spectroscopy, gal-PEI complexes formed with plasmid DNA were found to increase in size with increasing galactosylation (156+/-7 nm for 0%, 486+/-76 nm for 3.5%, 467+/-86 nm for 9.7% and 652+/-123 nm for 31% DS). Zeta potentials decreased in inverse proportion to DS (0%: 30+/-3 mV, 3.5%: 22+/-2 mV, 9.7%: 15+/-1 mV, 31%: -26+/-3.5 mV) suggesting a shielding effect by carbohydrate coupling. Cytotoxicity of gal-PEI was found to decrease with increasing galactosylation (MTT and LDH assay), no toxicity was detectable for polyplexes with plasmid DNA (LDH assay). The transfection efficiency of a reporter gene complexed with gal-PEI in a hepatocyte cell culture model (HepG2) expressing the asialoglycoprotein receptor was slightly but not significantly increased for galactosylated PEIs at a nitrogen to phosphate (N/P) ratio of 2 and strongly reduced at higher N/P ratios, compatible with only a minor targeting efficiency, strongly affected by DS. In NIH-3T3 mouse fibroblasts, increasing the DS led to a decreased transfection efficiency for all N/P ratios. Our study highlights the necessity of careful optimization of polyplex composition for active gene targeting.

Citing Articles

Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review.

Rodriguez-Castejon J, Beraza-Millor M, Solinis M, Rodriguez-Gascon A, Del Pozo-Rodriguez A Drug Deliv Transl Res. 2024; 14(10):2615-2628.

PMID: 38587758 PMC: 11383842. DOI: 10.1007/s13346-024-01583-0.


Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates.

Quadir M, Fehse S, Multhaup G, Haag R Molecules. 2018; 23(6).

PMID: 29861466 PMC: 6100100. DOI: 10.3390/molecules23061281.


Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.

Shilakari Asthana G, Asthana A, Kohli D, Vyas S Biomed Res Int. 2014; 2014:526391.

PMID: 25057492 PMC: 4098891. DOI: 10.1155/2014/526391.


A combinatorial library of bi-functional polymeric vectors for siRNA delivery in vitro.

Pelet J, Putnam D Pharm Res. 2012; 30(2):362-76.

PMID: 23054087 DOI: 10.1007/s11095-012-0876-4.


Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity.

Zhao Q, Hu Y, Zhou Y, Li N, Han M, Tang G Int J Nanomedicine. 2012; 7:3191-202.

PMID: 22811604 PMC: 3394466. DOI: 10.2147/IJN.S30909.